Concepedia

Daniel Afar

DA

Statistics

Publications

49

Citations

6.1K

H-Index

36

Active since

1989

Affiliations

University of California, Los Angeles(Current)

University of Ottawa

Howard Hughes Medical Institute

McGill University

PDL BioPharma (United States)

Daniel Afar is an author at University of California, Los Angeles specializing in life sciences, molecular biology, and medicine.

Publications per year

1989–2021

49

Publications

49

CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma

Eric D. Hsi, Roxanne Steinle, Balaji Balasa et al. · Clinical Cancer Research · 2008 · 560 citations · Full text

, , +15

Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu

Yu‐Tzu Tai, Myles Dillon, Weihua Song et al. · Blood · 2007 · 473 citations · Full text

, , +14

STEAP: A prostate-specific cell-surface antigen highly expressed in human prostate tumors

René Hubert, Igor Vivanco, Emily Chen et al. · Proceedings of the National Academy of Sciences · 1999 · 356 citations

, , +10

A phase 1, multicenter, open-label, dose escalation study of elotuzumab in patients with advanced multiple myeloma

Jeffrey A. Zonder, Ann Mohrbacher, Seema Singhal et al. · Blood · 2011 · 341 citations · Full text

, , +15

Oligomerization of the ABL Tyrosine Kinase by the Ets Protein TEL in Human Leukemia

Todd R. Golub, Andrei Goga, George F. Barker et al. · Molecular and Cellular Biology · 1996 · 340 citations · Full text

, , +16

1–5 of 49